全文获取类型
收费全文 | 3654篇 |
免费 | 274篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 121篇 |
妇产科学 | 154篇 |
基础医学 | 487篇 |
口腔科学 | 79篇 |
临床医学 | 316篇 |
内科学 | 709篇 |
皮肤病学 | 25篇 |
神经病学 | 576篇 |
特种医学 | 246篇 |
外科学 | 443篇 |
综合类 | 85篇 |
一般理论 | 1篇 |
预防医学 | 225篇 |
眼科学 | 71篇 |
药学 | 207篇 |
中国医学 | 1篇 |
肿瘤学 | 175篇 |
出版年
2021年 | 57篇 |
2018年 | 33篇 |
2017年 | 35篇 |
2016年 | 44篇 |
2015年 | 50篇 |
2014年 | 64篇 |
2013年 | 101篇 |
2012年 | 119篇 |
2011年 | 126篇 |
2010年 | 86篇 |
2009年 | 67篇 |
2008年 | 134篇 |
2007年 | 117篇 |
2006年 | 181篇 |
2005年 | 145篇 |
2004年 | 132篇 |
2003年 | 131篇 |
2002年 | 118篇 |
2001年 | 113篇 |
2000年 | 118篇 |
1999年 | 118篇 |
1998年 | 67篇 |
1997年 | 54篇 |
1996年 | 53篇 |
1995年 | 42篇 |
1994年 | 49篇 |
1993年 | 43篇 |
1992年 | 111篇 |
1991年 | 97篇 |
1990年 | 96篇 |
1989年 | 84篇 |
1988年 | 76篇 |
1987年 | 72篇 |
1986年 | 77篇 |
1985年 | 64篇 |
1984年 | 63篇 |
1983年 | 53篇 |
1982年 | 46篇 |
1981年 | 34篇 |
1980年 | 45篇 |
1979年 | 57篇 |
1978年 | 47篇 |
1977年 | 41篇 |
1976年 | 52篇 |
1975年 | 38篇 |
1974年 | 47篇 |
1973年 | 42篇 |
1971年 | 35篇 |
1970年 | 40篇 |
1969年 | 31篇 |
排序方式: 共有3940条查询结果,搜索用时 15 毫秒
31.
32.
James L. Kennedy Elizabeth A. Billett Fabio M. Macciardi Massimiliano Verga Thomas J. Parsons Herbert Y. Meltzer Jeffery Lieberman Janet A. Buchanan 《American journal of medical genetics. Part A》1995,60(6):558-562
Several groups have reported an association between schizophrenia and the MscI polymorphism in the first exon of the dopamine D3 receptor gene (DRD3). We studied this polymorphism using a North American sample (117 patients plus 188 controls) and an Italian sample (97 patients plus 64 controls). In the first part of the study, we compared allele frequencies of schizophrenia patients and unmatched controls and observed a significant difference in the total sample (P = 0.01). The second part of the study involved a case control approach in which each schizophrenia patient was matched to a control of the same sex, and of similar age and ethnic background. The DRD3 allele frequencies of patients and controls revealed no significant difference between the two groups in the Italian (N = 53) or the North American (N = 54) matched populations; however, when these two matched samples were combined, a significant difference was observed (P = 0.026). Our results suggest that the MscI polymorphism may be associated with schizophrenia in the populations studied. © 1995 Wiley-Liss, Inc. 相似文献
33.
Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability 总被引:1,自引:15,他引:1
La Spada AR; Peterson KR; Meadows SA; McClain ME; Jeng G; Chmelar RS; Haugen HA; Chen K; Singer MJ; Moore D; Trask BJ; Fischbeck KH; Clegg CH; McKnight GS 《Human molecular genetics》1998,7(6):959-967
X-linked spinal and bulbar muscular atrophy (SBMA) is caused by a CAG
repeat expansion in the first exon of the androgen receptor (AR) gene.
Disease-associated alleles (37-66 CAGs) change in length when transmitted
from parents to offspring, with a significantly greater tendency to shift
size when inherited paternally. As transgenic mice carrying human AR cDNAs
with 45 and 66 CAG repeats do not display repeat instability, we attempted
to model trinucleotide repeat instability by generating transgenic mice
with yeast artificial chromosomes (YACs) carrying AR CAG repeat expansions
in their genomic context. Studies of independent lines of AR YAC transgenic
mice with CAG 45 alleles reveal intergenerational instability at an overall
rate of approximately 10%. We also find that the 45 CAG repeat tracts are
significantly more unstable with maternal transmission and as the
transmitting mother ages. Of all the CAG/CTG repeat transgenic mice
produced to date the AR YAC CAG 45 mice are unstable with the smallest
trinucleotide repeat mutations, suggesting that the length threshold for
repeat instability in the mouse may be lowered by including the appropriate
flanking human DNA sequences. By sequence-tagged site content analysis and
long range mapping we determined that one unstable transgenic line has
integrated an approximately 70 kb segment of the AR locus due to
fragmentation of the AR YAC. Identification of the cis - acting elements
that permit CAG tract instability and the trans -acting factors that
modulate repeat instability in the AR YAC CAG 45 mice may provide insights
into the molecular basis of trinucleotide repeat instability in humans.
相似文献
34.
Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. 总被引:30,自引:0,他引:30
G V Stiegmann J S Goff P A Michaletz-Onody J Korula D Lieberman Z A Saeed R M Reveille J H Sun S R Lowenstein 《The New England journal of medicine》1992,326(23):1527-1532
BACKGROUND. Endoscopic sclerotherapy is an accepted treatment for bleeding esophageal varices, but it is associated with substantial local and systemic complications. Endoscopic ligation, a new form of endoscopic treatment for bleeding varices, may be safer. We compared the effectiveness and safety of the two techniques. METHODS. In this randomized trial we compared endoscopic sclerotherapy and endoscopic ligation in 129 patients with cirrhosis who had proved bleeding from esophageal varices. Sixty-five patients were treated with sclerotherapy, and 64 with ligation. Initial treatment for acute bleeding was followed by elective retreatment to eradicate varices. The patients were followed for a mean of 10 months, during which we determined the incidence of complications and recurrences of bleeding, the number of treatments needed to eradicate varices, and survival. RESULTS. Active bleeding at the first treatment was controlled by sclerotherapy in 10 of 13 patients (77 percent) and by ligation in 12 of 14 patients (86 percent). Slightly more sclerotherapy-treated patients had recurrent hemorrhage during the study (48 percent vs. 36 percent for the ligation-treated patients, P = 0.072). The eradication of varices required a lower mean (+/- SD) number of treatments with ligation (4 +/- 2 vs. 5 +/- 2, P = 0.056) than with sclerotherapy. The mortality rate was significantly higher in the sclerotherapy group (45 percent vs. 28 percent, P = 0.041), as was the rate of complications (22 percent vs. 2 percent, P less than 0.001). The complications of sclerotherapy were predominantly esophageal strictures, pneumonias, and other infections. CONCLUSIONS. Patients with cirrhosis who have bleeding esophageal varices have fewer treatment-related complications and better survival rates when they are treated by esophageal ligation than when they are treated by sclerotherapy. 相似文献
35.
In vitro histamine release induced by radiocontrast media and various chemical analogs in reactor and control subjects 总被引:1,自引:0,他引:1
M C Rice P Lieberman R L Siegle J Mason 《The Journal of allergy and clinical immunology》1983,72(2):180-186
The factors governing in vitro basophil histamine release induced by radiocontrast material (RCM) were evaluated by the use of two RCMs (diatrizoate and metrizamide) and three structural analogs of RCM (benzoic acid, diaminobenzoic acid, and 3-acetamidobenzoic acid) in basophil histamine-release studies. Diatrizoate was chosen because it is a commonly used RCM and is routinely administered as a hypertonic drug (958 mOsm/kg or greater). Metrizamide is a newly synthesized RCM and is routinely administered in isotonic form (approximately 280 mOsm/kg). The analogs were used in hope of identifying any structure-function relationship that might exist between RCMs and the activation of a proposed basophil membrane receptor responsible for the induction of de granulation. In addition, results in a control group of normal subjects were compared with those in a group of patients who had experienced anaphylactoid reactions to intravenous RCM. Basophils from both groups were incubated with diatrizoate and metrizamide to assess their relative sensitivity to these drugs. Both metrizamide and diatrizoate induced in vitro histamine release. Therefore hypertonicity is not an absolute requirement for RCM-induced in vitro basophil de granulation. Although there was a trend far reagents without a prosthetic group at position 5 on the benzene ring (especially 3-acetamidobenzoic acid) to induce more release of histamine than reagents with such a prosthetic group, differences between these reagents did not reach statistical significance. Therefore no clearcut structure-function relationship could be demonstrated. “Reactor” subjects released significantly-larger percents of their intracellular histamine than did “nonreactors” (p < 0.05). Degranulated cells retained their ability to exclude trypan blue, an observation suggesting that RCM-induced histamine release does not involve cell death. 相似文献
36.
Chemiluminescent and flow cytometric analysis of gamma interferon preincubation on neonatal and adult rat polymorphonuclear leukocytes.
下载免费PDF全文
![点击此处可从《Clinical and Vaccine Immunology : CVI》网站下载免费的PDF全文](/ch/ext_images/free.gif)
R R Wittler M M Lieberman D D Paine S L Muehlbauer J E Lima D M Sachanandani C A Pinney 《Clinical and Vaccine Immunology : CVI》1996,3(5):527-532
Gamma interferon (IFN-gamma) has multiple immunomodulating effects and has been postulated as a possible immunopotentiating agent for the prevention or treatment of neonatal infections. This report describes the effect of rat recombinant IFN-gamma on the oxidative burst activity and CD11b expression of neonatal and adult rat polymorphonuclear leukocytes (PMNL). Oxidative burst activity was assessed by chemiluminescence and dihydrorhodamine flow cytometry. Neonatal PMNL exhibited significantly less oxidative burst activity than did adult PMNL. IFN-gamma mildly enhanced the chemiluminescence response of PMNL from both the rat pups and adults, but this effect was not statistically significant when analyzed by a multivariate model of repeated-measures analysis of variance for both chemiluminescence and dihydrorhodamine flow cytometry. CD11b expression was also not significantly enhanced by IFN-gamma. 相似文献
37.
Lim DJ Rubenstein AE Evans DG Jacks T Seizinger BG Baser ME Beebe D Brackmann DE Chiocca EA Fehon RG Giovannini M Glazer R Gusella JF Gutmann DH Korf B Lieberman F Martuza R McClatchey AI Parry DM Pulst SM Ramesh V Ramsey WJ Ratner N Rutkowski JL Ruttledge M Weinstein DE 《Journal of neurogenetics》2000,14(2):63-106
38.
Horne G; Jamaludin A; Critchlow JD; Falconer DA; Newman MC; Oghoetuoma J; Pease EH; Lieberman BA 《Human reproduction (Oxford, England)》1998,13(11):3045-3048
Insemination with donor spermatozoa is an integral part of infertility
treatment. For the last 3 years in our unit, intrauterine insemination with
donor spermatozoa (IUID) has been used in preference to vaginal
insemination. In this retrospective study, patients were offered an initial
course of five single intrauterine inseminations with cryopreserved donor
spermatozoa and treatment was then reviewed. A total of 389 patients
received 1465 inseminations. In all, 1119 cycles were monitored using
luteinizing hormone serum analyses and 346 cycles using the urine home test
kits. The clinical pregnancy rate per insemination for the cycles monitored
by the serum assay was 18.0% (202/1119) compared with the urine cycles
(13.7%, 46/346) (P <05). The pregnancy loss rate was not significantly
different (14.4%, 29/202 and 21.7%, 10/46) (serum and urine cycles
respectively). The viable clinical pregnancy rate was significantly higher
(P <03) for the serum cycles than for the cycles using the urinary
monitoring (15.5%, 173/1119 and 10.4%, 36/346 respectively). The cycles
monitored by serum assay had a significantly higher cumulative viable
clinical pregnancy rate (P <0001) of 70.2% after nine inseminations
compared with the urine monitored cycles of 54.8%. The majority of patients
opted for the serum cycles, with a minority self-selecting the urine cycles
mainly for travelling convenience. The explanation for the significant
differences between the viable clinical pregnancy rates per insemination
and the cumulative viable clinical pregnancy rates may be due to the
sensitivity of the urine home test kit or the patients' interpretation of
the result.
相似文献
39.
D. Lieberman B. Dvoskin D. Lieberman S. Kahane M. Friedman 《European journal of clinical microbiology & infectious diseases》2002,21(4):307-309
The aims of this study were twofold: (i) to test for possible associations between serological evidence of acute Simkania negevensis (Sn) infection and acute exacerbation of chronic obstructive pulmonary disease and (ii) to examine the prevalence of past
infections with Sn in patients with chronic obstructive pulmonary disease. In 120 patients (63%) there was serological evidence
of past infection with Sn, which was not significantly different from the rate in a control population. In five hospitalizations
serological evidence existed of acute infection with Sn around the time of the exacerbation of chronic obstructive pulmonary
disease. In four of these cases, there was serological evidence of acute infection with at least one other respiratory pathogen.
It is concluded that Sn can be associated serologically with exacerbation of chronic obstructive pulmonary disease, in most
cases together with other respiratory pathogens. The implications of these findings should be investigated further.
Electronic Publication 相似文献
40.
C Arbesman I L Bernstein C W Bierman J S Bocles R Katz P L Lieberman K Mattucci E O Meltzer E Middleton J Noyes D S Pearlman H L Pence R G Slavin S L Spector 《The Journal of allergy and clinical immunology》1983,71(6):597-603
Fluocortin butyl (FCB) is a newly synthesized corticosteroid with a high ratio of topical to systemic activity. FCB was studied in a multi-center, double-blind, placebo-controlled trial of therapy of perennial rhinitis. The study was conducted between January and May 1981. Patients evaluated suffered from either chronic allergic or chronic nonallergic rhinitis or both. A total of 306 patients from 16 investigative centers were evaluated by comparing FCB to placebo. Three separate dosage regimens were employed. Patients received a total daily dose of 2, 4, or 8 mg. FCB was found to be an effective therapeutic agent. It reduced symptoms of nasal congestion, rhinorrhea, postnasal drainage, and sneezing. It also markedly reduced the use of concomitant medications (chlorpheniramine maleate and/or pseudoephedrine). Relief of symptoms was noted as early as the first week of therapy, and the degree of improvement increased progressively during the study. There was little difference between the relief produced by the 4 mg and 8 mg regimens. Both of these were superior to the 2 mg regimen. The drug was well tolerated; no significant side effects were noted. 相似文献